← Eichor
Study identifier: NCT06353620 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

Condition: Epilepsy · Angelman Syndrome · Dup15q Syndrome  ·  Sponsor: IRCCS Eugenio Medea

PhaseN/A
Planned participants120
Who can joinAll sexes, 6 Years to 75 Years
Healthy volunteersNo

About this study

Recent studies have shown that the aperiodic part of the signal (neuronal avalanches) of electroencephalography (EEG) contains important information about the dynamics of neuronal networks. Indeed, this has helped to identify functionally altered areas in patients with temporal epilepsy by simply using the resting EEG signal. Furthermore, it has been seen that the propagation of neuronal avalanches (VNs) correlates with the morphological organization of the cerebral cortex. Therefore, NAs represent a measure with direct utility for studying functional reorganization pre and post drug/surgical treatment. In addition, the aperiodic portion of the signal may represent a noninvasive measure of the excitation/inhibition relationship, which is known of being altered both in epilepsy and in some rare neurodevelopmental syndromes (example: Angelman and Dup15q)

This description comes directly from the study's public registry record.

Talk to the study team

Gian Marco Duma, PhD  ·  +39 0438414248  ·  gianmarco.duma@lanostrafamiglia.it

Darling Boachie  ·  +39 0438 41242  ·  segreteriascientifica.medea.veneto@lanostrafamiglia.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS E.MedeaConegliano, Treviso, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06353620